Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota; Division of Invasive Cardiology, University of Szeged, Second Department of Internal Medicine and Cardiology Center, Szeged, Hungary.
Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
JACC Cardiovasc Interv. 2018 Apr 9;11(7):615-625. doi: 10.1016/j.jcin.2017.10.052. Epub 2018 Mar 14.
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) has been rapidly evolving during recent years. With improvement in equipment and techniques, high success rates can be achieved at experienced centers, although overall success rates remain low. Prospective, randomized-controlled data regarding optimal use and indications for CTO PCI remain limited. CTO PCI should be performed when the anticipated benefit exceeds the potential risk. New high-quality studies of the clinical outcomes and techniques of CTO PCI are needed, as is the expansion of expert centers and operators that can achieve excellent clinical outcomes in this challenging patient and lesion subgroup. In the current review the authors summarize the latest publications in CTO PCI and provide an overview of the current state of the field.
经皮冠状动脉介入治疗(PCI)治疗慢性完全闭塞病变(CTO)近年来发展迅速。随着设备和技术的改进,在有经验的中心可以实现高成功率,尽管总体成功率仍然较低。关于 CTO PCI 的最佳使用和适应证的前瞻性、随机对照数据仍然有限。当预期获益超过潜在风险时,应进行 CTO PCI。需要新的高质量研究来评估 CTO PCI 的临床结果和技术,同时还需要扩大能够在这一具有挑战性的患者和病变亚组中实现良好临床结果的专家中心和术者的数量。在本综述中,作者总结了 CTO PCI 的最新文献,并概述了该领域的现状。